Navigation Links
Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at ASH Annual Meeting
Date:12/13/2011

SAN DIEGO, California, December 13, 2011 /PRNewswire/ --

-- Breadth of Pharmacokinetic Data Points to Tunable Half-life for Platform --

Pieris AG presented novel preclinical in vitro and in vivo data for its PRS-080 Anticalin hepcidin antagonist in an oral presentation at the American Society of Hematology Annual Meeting, the company announced today.  In a presentation entitled "Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK/PD Properties for the Treatment of Anemia in Different Patient Populations", the results demonstrated Pieris' PRS-080's ability to increase the serum iron levels in preclinical models by binding the hepcidin target with high affinity and specificity, while offering the flexibility of a tunable pharmacokinetic (PK) and pharmacodynamic (PD) profile.

"These studies in multiple preclinical species and models demonstrate the high level of control offered by the Anticalin approach in combination with PEGylation to create 'fit for purpose' PK/PD profiles that can match specific target biology across different patient populations," stated Laurent Audoly, Ph.D., Chief Scientific Officer of Pieris.  "In particular, the clear relationship between PEG formats and the resulting PK/PD profile for several PRS-080 variants tested in animal models provides an extremely encouraging basis for a rapid advance toward the clinic and creates a portfolio of molecules adapted for different hepcidin-dependent diseases."

The presentation at ASH included several in vivo animal studies of PRS-080's sub-nanomolar potency in binding hepcidin, which is a small peptide that plays a pivotal role in the regulation of iron levels in the blood.  In addition, Pieris researchers documented reliable drug half-life levels dependent on the size of the PEGylated compound.  In several preclinical models, a single dose of four different formulations of PRS-080 showed clear cor
'/>"/>

SOURCE Pieris AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
2. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
3. Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... YORK , Sept. 3,  2015 ... of vision care products considered for this report ... and readers. These products are primarily used by ... Products such as Rx lenses and contact lenses ... sunglasses, and readers are cosmetic products that can ...
(Date:9/3/2015)... 2015 About artificial organs ... are implanted or integrated into individuals to ... artificial heart, kidney, pancreas, and cochlear implants. ... and porous polypropylene), biologics, ceramics, and metals ... organs are incorporated with different technologies like ...
(Date:9/3/2015)... , Sept. 3, 2015 This Defibrillators ... to save millions of lives across globe. This report ... Kingdom of Saudi Arabia . Stakeholders for ... suppliers, government agencies and regulatory bodies. The ... from two perspectives: by products and by end users. ...
Breaking Medicine Technology:Vision Care Market in the US 2015-2019 2Global Artificial Organ Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... Scientists at Schepens Eye Research Institute have found that ... the health of blood vessels in the retina and ... published in the April 2 issue of PLoS ONE, ... treatment of diseases such as diabetic retinopathy and macular ...
... first-in-man Phase I clinical trial in healthy subjects- ... of this new vaccine candidate- Initial results expected ... vaccine supported by PATHVIENNA, April 7 Intercell ... I clinical trial with the company,s vaccine candidate ...
Cached Medicine Technology:Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 2Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels 3Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 2Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 3
(Date:9/4/2015)... ... , ... Mike Day, a former Navy SEAL who was shot 27 times ... in Kona on October 10th. , Mike is running the race to raise awareness ... the cutting-edge treatments that restore their quality of life. More than 300,000 ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for the ... October 9-10, 2015 at the Diplomat Resort & Spa has been announced and ... researchers at the top of their field and will be presenting sessions such ...
(Date:9/4/2015)... ... 2015 , ... Steven Winter Associates, Inc., (SWA) is pleased ... for the Residential Award of Merit by the Connecticut Green Building Council (CTGBC) ... highly competitive field of submissions, the net-zero energy residence will be honored at ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global ... that it has entered into a multi-year agreement with Health City Cayman Islands. ... the link between American healthcare, Jamaican healthcare and Health City Cayman Islands to ...
(Date:9/3/2015)... ... ... Allied Anesthesia is proud to announce a continuing partnership with St. Jude ... St. Jude was recently named one of the nation’s top stroke centers by The ... 10 hospitals in the state to earn the distinction. , The chances of ...
Breaking Medicine News(10 mins):Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... , CHICAGO, Nov. 24 The holiday season can be ... But for many people, especially those recovering from an eating ... failures and anxiety about an uncertain future. Family gatherings with ... be challenging and sometimes awkward. , "In my ...
... The Baylor Charles A. Sammons Cancer Center has become a ... cooperative groups in the United States. Funded by research grants ... trials to prevent and treat cancer in adults, and to ... this prestigious group will allow us to offer additional, important ...
... Nov. 24 As year-end approaches, many employees are ... year and next. To help you take advantage of these special ... highlights the following key year-end planning considerations for employees: , ... Many employees take advantage of the annual opportunity to save taxes ...
... Nov. 24 IPRO has achieved its third ... focused on fulfilling customer requirements, enhancing customer satisfaction ... ISO 9001:2008 by SGS International Certification Services means ... rigorous external audit encompassing operations at its offices ...
... ... of temporary physician staffing, is pleased to announce its agreement with VHA Inc., a ... ... -- Physician recruiting firm LocumTenens.com , a leading provider of temporary ...
... ... disease is largely unknown, but research will be presented at the upcoming 2009 Advances ... 3-6 in Hollywood, Florida, that may identify a causative mutation for Crohn’s disease. ... New York, NY ...
Cached Medicine News:Health News:When Holiday Meals Aren't a Gift 2Health News:When Holiday Meals Aren't a Gift 3Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 3Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:The Right Tax Moves for Employees to Make Before Year-End 4Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4
... The Allura Xper FD10 supports the ... concept that allows personalization of personalized user ... at tableside in one intuitive user interface. ... 3D-RA and StentBoost can be controlled from ...
The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems....
Allows surgeons to successfully complete coronary artery bypass without cross clamping or side biting. Saphaneous vein grafts may be attached to the aorta without sutures....
... The Nidek GYC-1000 delivers ... 1.7 W of energy and ... outlet. With compact design and ... be integrated with the Nidek ...
Medicine Products: